Gender Differences in Access to Health Care and Utilization Among Individuals with Atrial Fibrillation
Overview
This study investigates sex-based disparities in healthcare access and utilization among individuals with atrial fibrillation (AF).
Background
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, with increasing prevalence linked to longer life expectancy and improved survival rates. Despite a higher incidence in males, females with AF experience worse clinical outcomes, including higher risks of stroke and mortality, as reported in various studies.
Data Highlights
No numerical data or trial data presented in the source material.
Key Findings
Females with AF are less likely to receive timely evaluations for cardiovascular symptoms.
Women are less frequently referred for invasive procedures compared to men.
Guideline-directed medical therapies are less commonly prescribed to females with AF.
Sex-based disparities in AF management include lower rates of rhythm-control therapies and catheter ablation for women.
Delays in diagnosis and treatment are more pronounced in females with AF.
Clinical Implications
Healthcare providers should be aware of the disparities in access and treatment for females with AF.
Conclusion
The study highlights significant sex-based disparities in healthcare access and utilization among individuals with atrial fibrillation.
